NLRP3 and Hyperglycemia: Dulaglutide has been shown to reduce hyperglycemia-induced endothelial injury, potentially by preserving sirtuin 1 (SIRT1) levels and curbing mitochondrial fission [118], as well as via the downregulation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome [119].